- Home
- PASG vs SNES Comparison
PASG vs SNES Comparison
Compare PASG & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PASG
- SNES
- Stock Information
- Founded
- PASG 2017
- SNES 2004
- Country
- PASG United States
- SNES United States
- Employees
- PASG N/A
- SNES N/A
- Industry
- PASG Biotechnology: Pharmaceutical Preparations
- SNES Agricultural Chemicals
- Sector
- PASG Health Care
- SNES Industrials
- Exchange
- PASG Nasdaq
- SNES Nasdaq
- Market Cap
- PASG 20.3M
- SNES 21.0M
- IPO Year
- PASG 2020
- SNES 2016
- Fundamental
- Price
- PASG $6.95
- SNES $4.67
- Analyst Decision
- PASG Strong Buy
- SNES Strong Buy
- Analyst Count
- PASG 4
- SNES 1
- Target Price
- PASG $59.25
- SNES $10.00
- AVG Volume (30 Days)
- PASG 82.4K
- SNES 195.8K
- Earning Date
- PASG 08-12-2025
- SNES 08-07-2025
- Dividend Yield
- PASG N/A
- SNES N/A
- EPS Growth
- PASG N/A
- SNES N/A
- EPS
- PASG N/A
- SNES N/A
- Revenue
- PASG N/A
- SNES $2,093,000.00
- Revenue This Year
- PASG N/A
- SNES $130.53
- Revenue Next Year
- PASG N/A
- SNES $80.00
- P/E Ratio
- PASG N/A
- SNES N/A
- Revenue Growth
- PASG N/A
- SNES 36.89
- 52 Week Low
- PASG $5.12
- SNES $1.30
- 52 Week High
- PASG $26.60
- SNES $6.24
- Technical
- Relative Strength Index (RSI)
- PASG 53.66
- SNES 46.89
- Support Level
- PASG $5.51
- SNES $4.47
- Resistance Level
- PASG $6.27
- SNES $6.24
- Average True Range (ATR)
- PASG 0.66
- SNES 0.41
- MACD
- PASG 0.19
- SNES -0.13
- Stochastic Oscillator
- PASG 68.76
- SNES 19.03
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.